Seroprevalence of Chlamydophila pneumoniae in ischaemic heart disease

New Microbiologica

Volumn 33, Issue 4, 2010, Pages 381-385

  Monno, Rosa ^a   Fumarola, Luciana ^a   Trerotoli, Paolo ^a   Giannelli, Giorgia ^a   Correale, Michele ^b   Brunetti, Daniele ^b   Di Biase, Matteo ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

Author keywords

C. Pneumoniae; Heart disease; Serology

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

AGED; ARTICLE; BLOOD; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; EPIDEMIOLOGY; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; IMMUNOLOGY; ITALY; MALE; MICROBIOLOGY; MIDDLE AGED;

AGED; ANTIBODIES, BACTERIAL; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; ITALY; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; SEROEPIDEMIOLOGIC STUDIES;

CHLAMYDOPHILA PNEUMONIAE;

EID: 78650247680     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. ALTMAN R., ROUVIER J., SCAZZIOTA A., ABSI R.S., GONZALEZ C. (1999). Lack of association between prior infection with Chlamydia pneumoniae and acute or chronic coronary artery disease. Clin. Cardiol. 22, 85-90. (Pubitemid 29077395)
2. ARCARI C.M., GAYDOS C.A., NIETO F.J., KRAUSS M., NELSON K.E. (2005). Association between Chlamydia pneumoniae and acute myocardial infarction in young men in the United States military: the importance of timing of exposure measurement. Clin. Infect. Dis. 40, 1123-1130.
3. BLASI F., COSENTINI R., RACCANELLI R., MASSARI F.M., AROSIO C., TARSIA P., ALLEGRA L. (1997). A possible association of Chlamydia pneumoniae infection and acute myocardial infarction in patients younger than 65 years of age. Chest. 112, 309-312.
4. BLASI F, FAGETTI L, ALLEGRA L. (2000). Chlamydia pneumoniae detection in atherosclerotic plaques in Italy. J. Infect. Dis. 3, 444-446.
5. BOMAN J., HAMMERSCHLAG M.R. (2002). Chlamydia pneumoniae and amerosclerosis: critical assessment of diagnostic methods and relevance to treatment studies. Clin. Microbiol. Rev. 15, 1-20.
6. CAMPBELL L.A., KUO C.C., GRAYSTON J.T. (1998). Chlamydia pneumoniae and cardiovascular disease. Emerg. Infect. Dis. 4, 571-579.
7. CIERVO A., VISCA P., PETRUCCA A., BIASUCCI L.M., MASERI A., CASSONE A. (2002). Antibodies to 60-kilodalton heat shock protein and outer membrane protein 2 of Chlamydia pneumoniae in patients with coronary heart disease. Clin. Diagn. Lab. Immunol. 9, 66-74. (Pubitemid 34084277)
8. DANESH J., COLLINS R., PETO R. (1997). Chronic infections and coronary heart disease: is there a link? Lancet. 350, 430-436. (Pubitemid 27331246)
9. DUGAN J.P., FEUGE R.R., BURGESS D.S. (2002). Review of evidence for a connection between Chlamydia pneumoniae and atherosclerotic disease. Clin. Ther. 24, 719-735. (Pubitemid 34596942)
10. FAGERBERG B., GNARPE J., GNARPE H., AGEWALL S., WIKSTRAND J. (1999). Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: a prospective study in middle-aged to elderly men with treated hypertension. Stroke. 30, 299-305.
11. HOFFMEISTER A., ROTHENBACHER D., WANNER P., BODE G., PERSSON K., BRENNER H., HOMBACH V., KOENIG W. (2000). Seropositivity to chlamydial lipopolysaccharide and Chlamydia pneumoniae, systemic inflammation and stable coronary artery disease: negative results of a case-control study. J. Am. Coll. Cardiol. 35, 112-118.
12. JESPERSEN C.M., ALS-NIELSEN B., DAMGAARD M., HANSEN J.F., HANSEN S., HELØ O.H., HILDEBRANDT P., HILDEN J., JENSEN G.B., KASTRUP J., KOLMOS HJ., KJØLLER E., LIND I., NIELSEN H., PETERSEN L., GLUUD C. CLARICOR TRIAL GROUP. (2006). Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial. BMJ. 332, 22-27.
13. MAGGI P., MONNO R., CHIRIANNI A., GARGIULO M., CARITO V., FUMAROLA L., PERILLI F., LILLO A., BELLACOSA C., PANEBIANCO A., EPIFANI G., REGINA G. (2006). Role of chlamydia infection in the pathogenesis of atherosclerotic plaques in HIV-1-positive patients. In Vivo. 20, 409-413.
14. MAZZOLI S., TOFANI N., FANTINI A., SEMPLICI F., BANDINI F., SALVI A., VERGASSOLA R. ( 1998). Chlamydia pneumoniae antibody response in patients with acute myocardial infarction and their follow-up. Am. Heart. J. 135, 15-20.
15. MOVAHED M.R. (1999). Infection with Chlamydia pneumoniae and atherosclerosis: a review. JSC Med. Assoc. 95, 303-308.
16. MUHLESTEIN J.B. (1998). Bacterial infections and atherosclerosis. J. Investig. Med. 46, 396-402.
17. NOBEL M., DE TORRENTÉ A., PÉTER O., GENNÉ D. (1999). No serological evidence of association between Chlamydia pneumoniae infection and acute coronary heart disease. Scand. J. Infect. Dis. 31, 261-264. (Pubitemid 29389233)
18. O'CONNOR C.M., DUNNE M.W., PFEFFER M.A., MUHLESTEIN J.B., YAO L., GUPTA S., BENNER R.J., FISHER M.R., COOK T.D. (2003) Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial. JAMA. 290, 1459-1466.
19. RIDKER P.M., CUSHMAN M., STAMPFER M.J., TRACY R.P., HENNEKENS C.H. (1997). Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 336, 973-979. (Pubitemid 27152782)
20. RIDKER P.M., KUNDSIN R.B., STAMPFER M.J., POULIN S., HENNEKENS C.H. (1999). Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction. Circulation. 99, 1161-1164.
21. SAIKKU P., LEINONEN M., MATTILA K., EKMAN M.R., NIEMINEN M.S., MÄKELÄ RH., HUTTUNEN J.K., VALTONEN V. (1988). Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 2, 983-986.
22. SESSA R., DI PIETRO M., SANTINO I., DEL PIANO M., VARVERI A., DAGIANTI A., PENCO M. (1999). Chlamydia pneumoniae infection and atherosclerotic coronary disease. Am. Heart. J. 137, 1116-1119. (Pubitemid 30040737)
23. SESSA R., DI PIETRO M., SCHIAVONI G., SANTINO I., CIPRIANI P., ROMANO S., PENCO M., DEL PIANO M. (2001). Prevalence of Chlamydia pneumoniae in peripheral blood mononuclear cells in Italian patients with acute ischaemic heart disease. Atherosclerosis. 159, 521-525.
24. SISCOVICK D.S., SCHWARTZ S.M., COREY L., GRAYSTON J.T., ASHLEY R., WANG S.R, PSATY B.M., TRACY R.P., KULLER L.H., KRONMAL R.A. (2000). Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults: the Cardiovascular Health Study. Circulation. 102, 2335-2340.
25. VARVERI A., SGORBINI L., ROMANO S., AURIGEMMA G., DAGIANTI A. JR, SESSA R., DI PIETRO M., DEL PIANO M., DAGIANTI A., PENCO M. (1998). Chlamydia pneumoniae infection and cardiac ischemic syndromes. Cardiologia. 43, 1053-1058.
26. ZHU J., QUYYUMI A.A., MUHLESTEIN J.B., NIETO F.J., HORNE B.D., ZALLES-GANLEY A., ANDERSON J.L., EPSTEIN S.E. (2002). Lack of association of Helicobacter pylori infection with coronary artery disease and frequency of acute myocardial infarction or death. Am. J. Cardiol. 89, 155-158. (Pubitemid 34132902)